About us
Our mission is to provide first-in-class therapeutics to treat injury/damage to the central nervous system (CNS) in conditions such as spinal cord injury (SCI), glaucoma, and traumatic brain injury. Our treatment, AXER-204, hopes to rebuild connections between healthy and damaged neurons through the blocking of receptors that naturally inhibit axonal growth. We are currently approaching Phase 2 of testing.
- Website
-
http://www.renetx.com
External link for ReNetX Bio
- Industry
- Biotechnology
- Company size
- 2-10 employees
- Headquarters
- New Haven, CT
- Type
- Privately Held
- Specialties
- Biotechnology
Locations
-
Primary
Get directions
157 Church Street
19th Floor
New Haven, CT 06510, US